Usal - MediNews
Follow
2.3K views | +37 today
Usal - MediNews
Noticias médico-sanitarias en la red
Curated by Usalbiomedica
Your new post is loading...
Your new post is loading...
Scooped by Usalbiomedica
Scoop.it!

Libro Blanco de la Nutrición en España

Libro Blanco de la Nutrición en España | Usal - MediNews | Scoop.it

 

 "El Libro Blanco es fruto de un convenio específico firmado entre la Agencia Española de Seguridad Alimentaria y Nutrición (AESAN) y la propia Fundación Española de la Nutrición (FEN), supone una "hoja de ruta" de la nutrición en sus numerosas facetas, todas de gran actualidad..."

Usalbiomedica's insight:

Libro Blanco de la Nutrición en España. Fundación Española de la Nutrición: Madrid: FEN. 2013

more...
Scooped by Usalbiomedica
Scoop.it!

La Asociación Americana de Diabetes aconseja a diabéticos tomar estatinas para prevenir enfermedades del corazón

La Asociación Americana de Diabetes aconseja a diabéticos tomar estatinas para prevenir enfermedades del corazón | Usal - MediNews | Scoop.it
La Asociación Americana de Diabetes recomienda un objetivo de presión arterial diastólica menos estricto para las personas con diabetes y que todos los...
more...
No comment yet.
Rescooped by Usalbiomedica from E-Learning-Inclusivo (Mashup)
Scoop.it!

Aprender, Investigar, Gestionar, Publicar, Enseñar y Divulgar

Aprender, Investigar, Gestionar, Publicar, Enseñar y Divulgar | Usal - MediNews | Scoop.it
Artículo de José Ramón Alonso, director general de Políticas Culturales de la Junta de Castilla y León, con motivo del 10º aniversario de la Agencia DiCYT

Via Angel Pio Gonzalez Soto, juandoming
more...
Angel Pio Gonzalez Soto's curator insight, December 26, 6:13 AM

Ojalá todos hagamos de este título nuestro objetivo para 2015. Gracias, José Ramón.

Carlos Rodrigues Cadre's curator insight, Today, 8:13 AM

adicionar a sua visão ...

Scooped by Usalbiomedica
Scoop.it!

Ebola crisis 'likely to last a year'

Ebola crisis 'likely to last a year' | Usal - MediNews | Scoop.it
West Africa's Ebola crisis is likely to last until the end of 2015, says leading researcher Peter Piot, who helped to discover the virus in 1976.
more...
No comment yet.
Scooped by Usalbiomedica
Scoop.it!

What are those floaty things in your eye? - Michael Mauser - YouTube

What are those floaty things in your eye? - Michael Mauser - YouTube | Usal - MediNews | Scoop.it
View full lesson: http://ed.ted.com/lessons/what-are-those-floaty-things-in-your-eye-michael-mauser Sometimes, against a uniform, bright background such as a...
more...
No comment yet.
Scooped by Usalbiomedica
Scoop.it!

Determinan los factores de riesgo asociados al chagas en mujeres embarazadas

Determinan los factores de riesgo asociados al chagas en mujeres embarazadas | Usal - MediNews | Scoop.it

"Investigadores de Japón, EE UU y El Salvador han profundizado por primera vez en los factores de riesgo asociados a la enfermedad de Chagas en mujeres embarazadas salvadoreñas: la edad menor de 35 años y la anemia. Por ello, recomiendan introducir el análisis de sangre en torno a Trypanosoma cruzi, el parásito causante de la enfermedad, durante las visitas prenatales".

more...
No comment yet.
Scooped by Usalbiomedica
Scoop.it!

Nuevos fármacos reducen la anemia asociada a cánceres hematológicos

Nuevos fármacos reducen la anemia asociada a cánceres hematológicos | Usal - MediNews | Scoop.it
Un congreso en San Francisco aborda cómo financiar los tratamientos
more...
No comment yet.
Scooped by Usalbiomedica
Scoop.it!

Ebola vaccine trial 'interrupted'

Ebola vaccine trial 'interrupted' | Usal - MediNews | Scoop.it
The clinical trial of an Ebola vaccine in Switzerland has been interrupted after some patients complained of joint pains in their hands and feet.
more...
No comment yet.
Scooped by Usalbiomedica
Scoop.it!

Revolucionario tratamiento para la diabetes

Revolucionario tratamiento para la diabetes | Usal - MediNews | Scoop.it
La revista Science, informa que este puede ser un paso en la dirección correcta para una terapia de la diabetes que no requiere efectuar inyecciones constantes de insulina. Los científicos primero insertan células de médula ósea de ratones macho a los modelos femeninos de ratones cuya médula se ha dañado previamente de la radiación. Seis semanas después del trasplante, se identificaron las células masculinas en el páncreas de los ratones hembra.
more...
No comment yet.
Scooped by Usalbiomedica
Scoop.it!

Las matemáticas revelan que el tratamiento simultáneo contra el VIH y la hepatitis C aumenta su éxito / Noticias / SINC

Las matemáticas revelan que el tratamiento simultáneo contra el VIH y la hepatitis C aumenta su éxito / Noticias / SINC | Usal - MediNews | Scoop.it

"Un investigador español ha colaborado en un análisis matemático, publicado recientemente en la revista 'Science Translational Medicine', que concluye que la terapia conjunta frente al VIH en pacientes que además tienen hepatitis C aumenta el éxito en la lucha contra ambas infecciones. Entre ocho y nueve millones de personas en el mundo sufren sida y hepatitis C al mismo tiempo."

Usalbiomedica's insight:

 

Sherman, K. E., Guedj, J., Shata, M. T., Blackard, J. T., Rouster, S. D., Castro, M., ... & Perelson, A. S. (2014). Modulation of HCV replication after combination antiretroviral therapy in HCV/HIV co-infected patients. Science translational medicine, 6(246), 246ra98-246ra98.

more...
No comment yet.
Rescooped by Usalbiomedica from 4- PATIENT EMPOWERMENT & E-PATIENT by PHARMAGEEK
Scoop.it!

Cancer et essais cliniques : participation des patients aux traitements en cancérologie

Cancer et essais cliniques : participation des patients aux traitements en cancérologie | Usal - MediNews | Scoop.it
Les patients qui participent à un essai clinique, ainsi que leurs proches, témoignent, généralement, d’une expérience positive. Pourtant, seules 15 % des personnes traitées contre le cancer sont intégrées dans les essais cliniques. Peurs, idées fausses et réticences freinent encore la participation des malades.

Via Stéphanie Chevrel, Lionel Reichardt / le Pharmageek
more...
Scooped by Usalbiomedica
Scoop.it!

Dementia patients 'lack proper care'

Dementia patients 'lack proper care' | Usal - MediNews | Scoop.it
Dementia sufferers are not getting the care they need because the condition is not recognised as a terminal illness, two leading charities claim.
more...
No comment yet.
Scooped by Usalbiomedica
Scoop.it!

Un ensayo clínico aconseja reducir a la mitad los cambios de postura que se realizan a pacientes con patologías graves

Un ensayo clínico aconseja reducir a la mitad los cambios de postura que se realizan a pacientes con patologías graves | Usal - MediNews | Scoop.it

"Un ensayo clínico desarrollado por investigadores de la Unidad de Cuidados Intensivos (UCI) del Complejo Hospitalario Universitario de Granada recomienda reducir a la mitad los cambios de postura que se realizan a pacientes graves para evitar en ellos la aparición de úlceras, con el objetivo de reducir la aparición de otras complicaciones. El estudio ha sido publicado por la revista europea Intensive Care Medicine"

Usalbiomedica's insight:

Referencia: 

Manzano F, Colmenero M, Pérez-Pérez AM, Roldán D, Jiménez-Quintana Mdel M, Mañas MR, Sánchez-Moya MA, Guerrero C, Moral-Marfil MÁ, Sánchez-Cantalejo E, Fernández-Mondéjar E. Comparison of two repositioning schedules for the prevention of pressure ulcers in patients on mechanical ventilation with alternating pressure air mattresses. Intensive Care Med. 2014 Nov;40(11):1679-87. doi: 10.1007/s00134-014-3424-3. Epub 2014 Sep 5. PubMed PMID: 25189288.
more...
No comment yet.
Rescooped by Usalbiomedica from Cancer Immunotherapy Review
Scoop.it!

Combination Cancer Immunotherapy — A Virtual Roundtable - Life Science Leader Magazine

Combination Cancer Immunotherapy — A Virtual Roundtable - Life Science Leader Magazine | Usal - MediNews | Scoop.it
A series on the challenges and opportunities of using new agents to rally the immune system against cancer.

Via Krishan Maggon
more...
No comment yet.
Rescooped by Usalbiomedica from E-Learning-Inclusivo (Mashup)
Scoop.it!

LA CURIOSIDAD - Magazine INED21

LA CURIOSIDAD - Magazine INED21 | Usal - MediNews | Scoop.it
El aburrimiento se cura con la curiosidad. La curiosidad no se cura con nada.

Via Fernando de la Cruz Naranjo Grisales, juandoming
more...
No comment yet.
Rescooped by Usalbiomedica from Cancer Immunotherapy Review
Scoop.it!

New Therapies Available for Advanced Melanoma

New Therapies Available for Advanced Melanoma | Usal - MediNews | Scoop.it
An article about a host of new treatment options that have been produced in the last several years for patients with the skin cancer melanoma.

Via Krishan Maggon
more...
No comment yet.
Scooped by Usalbiomedica
Scoop.it!

NHS to 'unlock secrets' using DNA

NHS to 'unlock secrets' using DNA | Usal - MediNews | Scoop.it
A new genetics project could help "unlock a series of secrets about devastating diseases" including cancer and rare genetic disorders, the NHS says.
more...
No comment yet.
Scooped by Usalbiomedica
Scoop.it!

El BPA de los productos enlatados podría aumentar la presión arterial, según un estudio

El BPA de los productos enlatados podría aumentar la presión arterial, según un estudio | Usal - MediNews | Scoop.it

" Comer alimentos de latas revestidas con la sustancia química bisfenol A (BPA) podría aumentar la presión arterial, sugiere un estudio reciente.

El BPA ya se había vinculado con varios males, como problemas cardiacos, problemas del desarrollo en los niños e hipertensión. La sustancia se usa comúnmente en productos como botellas de plástico y recipientes para la comida, rellenos dentales y recibos de caja registradora. En las latas, el BPA se usa como revestimiento, dijeron los investigadores...

Usalbiomedica's insight:
rtículo por HealthDay, traducido por Hispanicare

FUENTE: Yun-Chul Hong, M.D., Ph.D., chair, department of preventive medicine, director, Environmental Health Center, Seoul National University College of Medicine, South Korea; Steven Gilbert, Ph.D., director and founder, U.S. Institute of Neurotoxicology and Neurological Disorders, Seattle; statement, Steven Hentges, Ph.D., Polycarbonate/BPA Global Group, American Chemistry Council; Dec. 8, 2014, Hypertension, online

more...
No comment yet.
Rescooped by Usalbiomedica from Cancer Immunotherapy Review
Scoop.it!

Frontiers | Exploiting Synergy: Immune-Based Combinations in the Treatment of Prostate Cancer | Tumor Immunity

Frontiers | Exploiting Synergy: Immune-Based Combinations in the Treatment of Prostate Cancer | Tumor Immunity | Usal - MediNews | Scoop.it

Cancer treatment is being revolutionized by the emergence of immunotherapies such as immune checkpoint inhibitors and therapeutic cancer vaccines. Prostate cancer is amenable to such therapeutic approaches. The improved understanding of the relationship between the immune system and tumors has allowed therapeutic targeting of immune checkpoints and tumor associated antigens to be developed. Furthermore, interventions used in prostate cancer are capable of impacting the immune system. As demonstrated by preclinical data and emerging clinical data, radiation therapy, anti-androgen therapy, and chemotherapy can be used with immunotherapies to obtain synergistic results. Current and future clinical trials will further investigate these principles as immunotherapeutics are combined with each other and standard therapies for optimal clinical utility.


Via Krishan Maggon
more...
Krishan Maggon 's curator insight, December 15, 3:12 AM
Front. Oncol., 12 December 2014 | doi: 10.3389/fonc.2014.00351Exploiting synergy: immune-based combinations in the treatment of prostate cancerMauricio Burotto1, Nishith Singh2, Christopher R. Heery1, James L. Gulley1* and Ravi A. Madan11Genitourinary Malignancies Branch, National Cancer Institute, National Institute of Health, Bethesda, MD, USA2Indiana University Health Arnett, Lafayette, IN, USA
Rescooped by Usalbiomedica from Cancer Immunotherapy Review
Scoop.it!

Immune-based therapies for childhood cancer : Nature Reviews Clinical Oncology : Nature Publishing Group

Immune-based therapies for childhood cancer : Nature Reviews Clinical Oncology : Nature Publishing Group | Usal - MediNews | Scoop.it

Immunotherapies for cancer are demonstrating increasing success. These agents can amplify existent antitumour immunity or induce durable antitumour immune responses in a wide array of cancers. The spectrum of immunotherapeutics is broad, spanning monoclonal antibodies and their derivatives, tumour vaccines, and adoptive therapies using T cells and natural killer cells.

 

Only a small number of immunotherapies have been tested in paediatric cancers, but impressive antitumour effects have already been observed. Mononclonal antibodies targeting GD2 that induce antibody-dependent cell-mediated cytotoxicity improve survival in high-risk neuroblastoma. Bi-specific monoclonal antibodies that simultaneously target CD19 and activate T cells can induce remission in acute B-cell lymphoblastic leukaemia (B-ALL) and adoptive immunotherapy using T cells genetically engineered to express chimeric antigen receptors targeting CD19 induce impressive responses in B-ALL. Efforts are underway to generate and test new immunotherapies in a wider array of paediatric cancers. Major challenges include a need to identify immunotherapy targets on the most lethal childhood cancers, to expand availability of technology-intense platforms, such as adoptive cell therapy, to optimize management of novel toxicities associated with this new class of cancer therapies and to determine how best to incorporate these therapies into standard treatment paradigms.


Via Krishan Maggon
more...
Krishan Maggon 's curator insight, December 14, 2:39 AM
Immune-based therapies for childhood cancerCrystal L. Mackall,Melinda S. Merchant& Terry J. FryAffiliationsContributionsCorresponding authorNature Reviews Clinical Oncology 11, 693–703 (2014) doi:10.1038/nrclinonc.2014.177Published online 28 October 2014
Scooped by Usalbiomedica
Scoop.it!

Halving of malaria deaths celebrated

Halving of malaria deaths celebrated | Usal - MediNews | Scoop.it
Global efforts over the past decade have halved the number of people dying from malaria - a tremendous achievement, says the World Health Organization.
more...
No comment yet.
Scooped by Usalbiomedica
Scoop.it!

Bilingüismo y párkinson comparten las mismas áreas de control ejecutivo en el cerebro

Bilingüismo y párkinson comparten las mismas áreas de control ejecutivo en el cerebro | Usal - MediNews | Scoop.it

"Un nuevo estudio sugiere que la enfermedad de Parkinson, ya desde sus primeros estadios, afecta a la capacidad de gestionar en las personas bilingües las dos lenguas, lo que dificulta los cambios y la gestión de la interferencia de la lengua que no está en uso."

 

Usalbiomedica's insight:

Gabriele Cattaneo, Marco Calabria, Paula Marne, Alexandre Gironell, Jubin Abutalebi, Albert Costa (2014), "The role of executive control in bilingual language production: A study with Parkinson's disease individuals",Neuropsychologia, volumen 66, enero 2015, pp. 99-110. doi:10.1016/j.neuropsychologia.2014.11.006.

more...
No comment yet.
Rescooped by Usalbiomedica from 2- HEALTHCARE SOCIAL MEDIA by PHARMAGEEK
Scoop.it!

FDA and Social Media: Impact on Perscription Drug Advertising

FDA and Social Media: Impact on Perscription Drug Advertising | Usal - MediNews | Scoop.it

Studies have shown that 60% of Americans turn to the internet for medical advice. It’s obvious how social media naturally seems like another method pharmaceutical companies can quickly and easily advertise to consumers. Are pharmaceutical companies alone in trying to tap into our unconscious? Would you be surprised if I told you that you could be inadvertently perpetuating such behavior?  

By: Austin Chaing, MD.

The US is one of the few countries that permits direct-to-consumer advertising of pharmaceuticals. We’ve all see the ads that ramble on about all the potential risks and side effects associated with various medications. No doubt you’ve probably been bombarded with flashy sidebars on the internet promoting one medication or another — some creepily relevant to our own medical conditions. As social media became a part of life for many of us, pharmaceutical companies were quickly to exploit the medium. Platforms like Twitter are free to operate and far-reaching. Only until recently has there been a greater effort to regulate the content being disseminated to the public.

In this day and age, Big Pharma might not be quite as cavalier as you might expect. A quick search on Twitter says it all. Almost every major drug company has a verified Twitter account. While companies are generous in providing general medical knowledge or the update here or there that says the company is actively researching condition X, seldom do you find anything plugging a specific product.

Direct-to-consumer advertising on social media has revealed many challenges. Sometimes 140 characters simply isn’t enough to convey all the benefits let alone the black box warnings a drug may possess. The “Twitterverse” is an international community, and messages applicable to one population could wrongfully passed on to another. Some medications banned by one country may be promoted by individuals and corporations of another country. In fact, Glaxo Smith-Kline and AstraZeneca reportedly have disclaimers on their Facebook sites saying that information is “intended for US residents/consumers only.” 

But how often are pharmaceutical companies really harping on their own products on Twitter? More likely than not, individuals are weighing in with their micro-reviews on Twitter. Some would argue that these posts could impact consumers. Bad experiences often motivate people to say something. What about the positive reviews? Who is really behind the tweets gushing about Medication XYZ? 

So far, individuals aren’t being held accountable for claims they make. Should the FDA as individuals to report their disclosures? Should the FDA be verifying all social media posts that mention a drug? Something tells me there no room in the FDA budget for this. Others would go as far as to argue that this violates the first amendment.

In June 2014, the FDA released suggested guidelines to regulate social media posts by drug companies. (Click on blue text for link) Essentially for every post claiming benefit of a certain medication, the FDA is demanding equal reporting of risks and a link to more information to go with it. Sounds impossible to squeeze all that into 140 characters, and perhaps it these guidelines were meant to deter drug companies from using social media altogether to promote their products.

Let’s take a step back to ask ourselves a few questions:

Do you think the FDA is being fair to drug companies, or should we be hearing about the risks/benefits of toilet paper or have the nutrition facts be mandated for a tweet promoting candy bars? Do you think such regulations are resulting in adverse effects by deterring some individuals from learning about some medications? As mentioned earlier, should individuals be subjected to the same rules? Should all our tweets be regulated as potential advertisement for whichever product is mentioned?

 


Via Plus91, Pharmacomptoir / Corinne Thuderoz, Lionel Reichardt / le Pharmageek
more...
Erika Kettlewell's curator insight, December 4, 3:26 AM

This is a very interesting article about how social media does not have the regulation laws that traditional advertising has in place. Living in Canada where the pharmaceutical companies are not allowed to advertise, we do not have the pushy ads on TV unless we are viewing an American channel.  What I find most note worthy is the fact that I can go onto Twitter and find any pharmaceutical company and read minimal information in a 140 characters or less. That is not giving me the proper information and also is something that needs to be taking into consideration. The majority of countries do not allow these types of ads but using social media these "posts" can be viewed from anywhere in the world. In a lot of ways it is a smart marketing tool until further laws and regulations get put into place but it does not however educate consumers fully of the benefits or potential risks of the medication.

Scooped by Usalbiomedica
Scoop.it!

HeartFlow FFR-CT evalúa el flujo sanguíneo

HeartFlow FFR-CT evalúa el flujo sanguíneo | Usal - MediNews | Scoop.it
Una pieza de información clínica que los profesionales de la salud utilizan para determinar el alcance de una obstrucción en el corazón o en una arteria coronaria, es un valor llamado reserva fraccional de flujo (RFF). La obtención de este valor, se requiere un procedimiento invasivo llamado cateterismo cardíaco.
more...
No comment yet.
Scooped by Usalbiomedica
Scoop.it!

IV PREMIO NACIONAL DE INVESTIGACIÓN EN CÁNCER “DOCTORES DIZ PINTADO" : Centro de investigación del Cáncer - Comprehensive Cancer Center Research

IV PREMIO NACIONAL DE INVESTIGACIÓN EN CÁNCER “DOCTORES DIZ PINTADO" : Centro de investigación del Cáncer - Comprehensive Cancer Center Research | Usal - MediNews | Scoop.it

La Fundación de Investigación del Cáncer de la Universidad de la Salamanca (FICUS) – Centro de Investigación del Cáncer (CIC) convoca el IV Premio Nacional de Investigación en Cáncer “DOCTORES DIZ PINTADO”, en memoria de los Drs. Manuel y Alfonso Diz Pintado, con el objeto  de promover y reconocer la contribución de los jóvenes investigadores españoles al desarrollo científico de la Investigación Oncológica.

El premio consiste en una dotación única de 15.000 euros (quince mil euros), aplicándose, en su caso, las retenciones fiscales vigentes, un diploma acreditativo y un objeto conmemorativo. Dicho premio se concede en memoria de los Drs. Manuel y Alfonso Diz Pintado, para premiar la labor investigadora en Oncología de jóvenes científicos españoles nacidos a partir de 1969.

Las solicitudes para participar en esta convocatoria habrán de remitirse antes de las 14:00 horas del día 4 de diciembre del 2014.

Toda la información sobre esta convocatoria está disponible en: http://t.co/oTqp45NvIy

more...
No comment yet.